Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Peptide Antibiotics Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of diseases such as bacterial skin, blood stream, and hospital acquired infections
5.1.1.2. Rising need for peptide antibiotics in hospitals and clinics
5.1.1.3. Improvement in healthcare infrastructure facility
5.1.2. Restraints
5.1.2.1. Stringent reimbursement policy
5.1.3. Opportunities
5.1.3.1. Rising product approvals and product launches and R&D initiatives
5.1.3.2. Emerging use in regeneration of skin/bone, prevention of implant-associated infections, cancer therapy and gene delivery
5.1.4. Challenges
5.1.4.1. Concerns related to instability and toxicity of peptide antibiotics
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Peptide Antibiotics Market, by Type
6.1. Introduction
6.2. Non-Ribosomal Synthesized Peptide Antibiotics
6.3. Ribosomal Synthesized Peptide Antibiotics

7. Peptide Antibiotics Market, by Disease
7.1. Introduction
7.2. Blood Stream Infections
7.3. HABP/VABP
7.4. Skin Infections

8. Peptide Antibiotics Market, by Route of Administration
8.1. Introduction
8.2. Injectable
8.3. Oral
8.4. Topical

9. Peptide Antibiotics Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies

10. Americas Peptide Antibiotics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Peptide Antibiotics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Peptide Antibiotics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. AbbVie Inc.
14.1.3. Dr. Reddy’s Laboratories Ltd.
14.1.4. Eli Lilly & Company
14.1.5. Eugia US LLC
14.1.6. Fresenius SE & Co. KGaA
14.1.7. GlaxoSmithKline PLC
14.1.8. Merck & Co., Inc.
14.1.9. Novartis AG
14.1.10. Novo Holdings A/S
14.1.11. Pfizer Inc.
14.1.12. Sanofi S.A.
14.1.13. Savara Inc.
14.1.14. Teva Pharmaceutical Industries Ltd.
14.1.15. Theravance Biopharma
14.2. Key Product Portfolio

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing



List of Figures

FIGURE 1. PEPTIDE ANTIBIOTICS MARKET RESEARCH PROCESS
FIGURE 2. PEPTIDE ANTIBIOTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. PEPTIDE ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PEPTIDE ANTIBIOTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PEPTIDE ANTIBIOTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PEPTIDE ANTIBIOTICS MARKET DYNAMICS
FIGURE 7. PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 10. PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 12. PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. PEPTIDE ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. PEPTIDE ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. PEPTIDE ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. PEPTIDE ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. PEPTIDE ANTIBIOTICS MARKET SIZE, BY NON-RIBOSOMAL SYNTHESIZED PEPTIDE ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PEPTIDE ANTIBIOTICS MARKET SIZE, BY RIBOSOMAL SYNTHESIZED PEPTIDE ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 9. PEPTIDE ANTIBIOTICS MARKET SIZE, BY BLOOD STREAM INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PEPTIDE ANTIBIOTICS MARKET SIZE, BY HABP/VABP, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PEPTIDE ANTIBIOTICS MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 13. PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PEPTIDE ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 17. PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PEPTIDE ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PEPTIDE ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 35. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 39. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 57. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. INDIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 61. INDIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. JAPAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 69. JAPAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. THAILAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 93. THAILAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 106. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. EGYPT PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 110. EGYPT PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 114. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 118. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 130. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. NORWAY PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 142. NORWAY PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. POLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. POLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 146. POLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 150. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. TURKEY PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 178. TURKEY PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. PEPTIDE ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. PEPTIDE ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. PEPTIDE ANTIBIOTICS MARKET LICENSE & PRICING